(News Bulletin 247) – Euroland announced on Wednesday that it had initiated coverage of the DMS stock with a buy recommendation, acknowledging the ‘international influence’ of the specialist in medical diagnostics.
While acknowledging that the share’s stock market journey has been ‘very hectic’, the analyst is confident about the group’s positioning, as well as its short, medium and long-term prospects.
From the design office’s point of view, DMS is at the dawn of a ‘new page in its history’, combining both growth and a strong improvement in profitability.
Euroland highlights in particular the ambitions of the new strategic plan presented in October 2022, which aims to transform the company into a key European player in medical imaging.
Its valuation is two euros per share.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
